Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Preferred Pharmaceuticals – Recall of losartan
March 28, 2019 - Preferred Pharmaceuticals announced a voluntary, consumer-level recall of multiple lots of losartan tablets due to the presence of an impurity, N-Methylnitrosobutyric acid (NMBA), found in finished product.
